Private Equity
Although 'take private' deals achieve lower average returns than private buyouts, a new study suggests, their performance tends to be less volatile and subject to lower write-off rates.
2 min read · 20 September 2013
The pharmaceutical royalties-focused firm is expected to close Fund III above target after coming to market in mid-2012.
2 min read · 20 September 2013
The exit comes as the firm is raising AXA Expansion III, an SME-focused fund with a €400m target that is approaching a third close.
3 min read · 20 September 2013
The US firm has acquired a Danish clinical services business, less than a year after it raised its latest fund in just eight weeks.
2 min read · 20 September 2013
The recently rebranded firm, with a focus on mezzanine lending in China, expects to have raised $50m by the end of April for its latest $200m fund.
2 min read · 20 September 2013
The Paris-based firm expects private equity capital that reaches the end of its investment period to be reinvested in the asset class, helping fundraising increase year-over-year.
2 min read · 20 September 2013
Investments based solely on a leverage strategy, absent of significant operational improvements, are not only passé, but also unwise.
3 min read · 20 September 2013
The system committed to TowerBrook, SVB Capital, Bayview and Levine Leichtman, continuing on its investment pace as one of the most active alternative investors in the market.
2 min read · 20 September 2013
Sales to strategic buyers accounted for half of the 118 realisations in Africa in the last five years, a new study suggests, helping PE achieve returns nearly twice those of regional public markets.
2 min read · 20 September 2013
The lower mid-market firm has invested roughly $71m in four transactions since launching the fund in 2011.
2 min read · 20 September 2013
